A case of rapid improvement of severe psoriasis during molecular-targeted therapy using an epidermal growth factor receptor tyrosine kinase inhibitor for metastatic lung adenocarcinoma

J Am Acad Dermatol. 2012 Jun;66(6):e251-3. doi: 10.1016/j.jaad.2011.08.009.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / epidemiology
  • Comorbidity
  • Erlotinib Hydrochloride
  • Humans
  • Lung Neoplasms / epidemiology
  • Male
  • Middle Aged
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride